Stockreport

Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC

VINCERX PHARMA INC  (VINC) 
PDF Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025 Trading to be permanently suspended by Nasdaq at t [Read more]